Health Trials

Heart Failure Patients

2

Review clinical trials related to Heart Failure Patients. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor

Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This multicentre study will validate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse outpatient HF population.

Participants needed: 360
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Health Network, TorontoUpdated: Mar 4, 2026Locations: 3Duration: 1 Year
Eligibility criteria

broad age range (> 18 years of age) [+5]

Unable to perform a CPET based on the standard protocol [+4]

Read more
Status: Not yet recruiting

Soluble ST2 in Patients With Heart Failure"

1. The aim of this study was to explore the relationship between peripheral circulating serum soluble suppression of tumorigenicity-2 (sST2) levels and inflammatory biomarkers in patients with heart failure 2. Additive role of sST2 to NPs in of heart failure patients

Participants needed: 100
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: May 23, 2024
Eligibility criteria

patients 18-80 years. [+2]

Patients <18 years [+4]

Read more